Details:

Personal Author:
Grohskopf, Lisa A.; Bresee, Joseph S.; Cox, Nancy (Nancy J.); Shimabukuro, Tom T.;
Grohskopf, Lisa A.; Bresee, Joseph S.; Cox, Nancy (Nancy J.); Shimabukuro, Tom T.; Less -
Corporate Authors:
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.; United States. Advisory Committee on Immunization Practices.;
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office.; National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division.; United States. Advisory Committee on Immunization Practices.; Less -
Description:
In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ?6 months in the United States. Annual influenza vaccination of all persons aged ?6 months continues to be recommended. This document 1) describes influenza vaccine virus strains included in the U.S. seasonal influenza vaccine for 2012-13; 2) provides guidance for the use of influenza vaccines during the 2012-13 season, including an updated vaccination schedule for children aged 6 months through 8 years and a description of available vaccine products and indications; 3) discusses febrile seizures associated with administration of influenza and 13-valent pneumococcal conjugate (PCV-13) vaccines; 4) provides vaccination recommendations for persons with a history of egg allergy; and 5) discusses the development of quadrivalent influenza vaccines for use in future influenza seasons. Information regarding issues related to influenza vaccination that are not addressed in this update is available in CDC's Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 and associated updates. Reported by Lisa Grohskopf, Timothy Uyeki, Joseph Bresee, Nancy Cox, Influenza Div, National Center for Immunization and Respiratory Diseases; Tom Shimabukuro, Immunization Safety Office, National Center for Zoonotic and Emerging Infectious Diseases, CDC. 6 p. (p. 613-618)
Content Notes:
none
Subject:
[+]
Antigens, Viral/immunology
Immunization Schedule
Influenza, Human/epidemiology
Influenza, Human/prevention & Control
Influenza A Virus, H1N1 Subtype/immunology
Influenza A Virus, H3N2 Subtype/immunology
Influenza B Virus/immunology
Influenza Vaccines/administration & Dosage
Influenza Vaccines/adverse Effects
Influenza Vaccines/immunology
Influenza Vaccines/supply & Distribution
Pneumococcal Vaccines/administration & Dosage
Pneumococcal Vaccines/adverse Effects
Practice Guideline
Seasons
Seizures, Febrile/etiology

Source:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 61, no. RR-32, 613-618.;
Pubmed ID:
22895385
Document Type:
Journal Article;
Genre:
Guideline;
Place as Subject:
United States;
Collection(s):
Guidelines and Recommendations
Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:
[+]
urn:sha256:229b55f0b240c693cabe283a53922f38be99b5325d523c7d39d2ecbefceca6bb
File Type:

Supporting Files

• No Additional Files

More +